Fact Sheet: President Biden Reignites Cancer Moonshot to End Cancer as We Know It (Connecting the Dots: NIH, NCI, CDC, FDA, DoD, OMB, DPC, DOE, ACS & the Soros Funded Think Tanks All Networking)
The Whitehouse briefing-room statements-releases
Biden-Harris Administration Sets Goal of Reducing Cancer
Death Rate by at least 50 Percent Over the Next 25 Years, and Improving the
Experience of Living with and Surviving Cancer
As Vice President, in 2016, Joe Biden launched the Cancer Moonshot with the mission
to accelerate the rate of progress against cancer. The cancer and patient
community and medical researchers responded with tremendous energy and
ingenuity.
Today, President Biden is reigniting the Cancer
Moonshot with renewed White House leadership of this effort. Because of recent
progress in cancer therapeutics, diagnostics, and patient-driven care, as well
as the scientific advances and public health lessons of the COVID-19 pandemic,
it’s now possible to set ambitious goals: to reduce the death rate from
cancer by at least 50 percent over the next 25 years, and improve the
experience of people and their families living with and surviving cancer— and,
by doing this and more, end cancer as we know it today.
The President and First Lady Jill Biden are also announcing a call to
action on cancer screening to jumpstart progress on screenings that were
missed as a result of the pandemic, and help ensure that everyone in the United
States equitably benefits from the tools we have to prevent, detect, and
diagnose cancer.
Building on a Quarter Century of Bipartisan Support, Public Health Progress,
and Scientific Advances
Over the first 20 years of this century, the age-adjusted death rate from
cancer has fallen by about 25 percent, which means more people are surviving
cancer and living longer after being diagnosed with cancer. That was enabled by
progress on multiple fronts.
·
Science brought us treatments that target
specific mutations in many types of cancer –for example, in certain types of
lung cancer, leukemia, and skin cancers.
·
It has also provided therapies that use our
immune system to detect and kill cancer cells and these immunotherapies are
making a big difference in certain skin cancers, blood cancers, and others.
·
We also have cancer vaccines – like
the HPV vaccine –which prevents the cause of up to seven kinds of cancer.
·
We developed tools, like low-dose CT scans
and refined use of colonoscopies, which help us detect lung cancer and
colorectal cancers early when there are better treatment options.
·
Starting in the early 1990s, we also made
progress against tobacco use through targeted public health education campaigns
as well as new, more effective approaches to smoking cessation. We have
seen a 50 percent decrease in adult long-term cigarette smoking and a 68
percent drop in smoking rates among youth.
Five years ago, with the bipartisan passage and enactment
of the 21st Century Cures Act, Congress invested $1.8 billion, providing
seven years of new funding for cancer research in many areas including studies
on cancer disparities, new clinical trial networks to drive drug discovery, and
innovative projects examining childhood cancer. The law streamlined
cancer-related decision-making at the FDA through the formation of an Oncology Center
of Excellence, so that effective treatments can be approved faster and patients
can have more direct access to information about the regulatory process.
First Lady Jill Biden’s advocacy for cancer education and
prevention began in 1993, when four of her friends were diagnosed with breast
cancer. Following that year, she launched the Biden Breast Health Initiative to
educate Delaware high school girls about the importance of cancer
prevention. As First Lady she continues her work emphasizing early detection
efforts and the patient, family and caregiver experience with cancer.
She will also stress the importance of cancer screenings, especially those
delayed or put off due to the COVID-19 pandemic, and will urge government
partners, the business community, and non-profit sectors to help make
screenings more accessible and available to all.
At the White House, then-Vice President Biden brought
together a task force and challenged the public and private sectors to join
together in making progress. Companies, patient groups, universities, and
foundations worked together to forge new partnerships and launch new programs.
The Biden-Harris Administration Has Maintained This
Commitment
In the President’s first budget, he sustained strong funding for biomedical and
health research with increased funding
for the NIH and NCI, and full funding
for the 21st Century Cures Act and the Beau Biden Cancer
Moonshot Initiative at the NCI.
President Biden proposed a bold new vision for biomedical and health research
in the Advanced Research
Projects Agency for Health (ARPA-H). The goal of this entity is to improve
the U.S. government’s capabilities to speed research that can improve human
health — to improve our ability to prevent, detect, and treat a range of
diseases including cancer, infectious diseases, Alzheimer’s disease, and many
others. ARPA-H funding has already been included in appropriation and
authorization bills pending in Congress.
President Biden committed to a bilateral effort with
the United Kingdom to take on the challenges of cancer together. This has
already resulted in a November 2021 US-UK Cancer Scientific Meeting of
leadership, patient advocates, and oncology research experts which produced
recommendations for how the two nations can work in partnership to make even
more urgent progress on cancer.
The Biden-Harris Administration has also prioritized
strengthening health care for the American people by lowering health care
costs and expanding coverage. The President’s health care agenda is the biggest
expansion of affordable health care in a decade, and includes cutting
prescription drug costs by letting Medicare negotiate prices; strengthening the
Affordable Care Act and reducing premiums for 9 million Americans; improving
Medicare benefits by capping out-of-pocket costs on drugs, including cancer
drugs, purchased at a pharmacy; and covering millions of uninsured Americans in
states that have failed to expand Medicaid.
New Goals for the Cancer Moonshot
Based on the progress made and the possibility before us, President Biden today
set new national goals for the Cancer Moonshot:
·
Working together over the next 25 years, we
will cut today’s age-adjusted death rate from cancer by at least 50 percent.
·
We will improve the experience of people
and their families living with and surviving cancer.
Taken together, these actions will drive us toward ending
cancer as we know it today.
There’s so much that can be done.
·
To diagnose cancer sooner — Today, we know
cancer as a disease we often diagnose too late. We must increase access to
existing ways to screen for cancer, and support patients through the process of
diagnosis. We can also greatly expand the cancers we can screen for. Five years
ago, detecting many cancers at once through blood tests was a dream. Now new
technologies and rigorous clinical trials could put this within our reach.
Detecting and diagnosing cancers earlier means there may be more effective
treatment options.
·
To prevent cancer — Today, we know cancer
as a disease we have few good ways to prevent. But now, scientists are asking
if mRNA technology, used in the safe and effective COVID-19 vaccines to teach
your body to fight off the virus, could be used to stop cancer cells when they
first appear. And we know we can address environmental exposures to cancer,
including by cleaning up polluted sites and delivering clean water to American
homes, for example, through the Bipartisan Infrastructure Law.
·
To address inequities — Today, we know
cancer as a disease for which there are stark inequities in access to cancer
screening, diagnostics and treatment across race, gender, region, and
resources. We can ensure that every community in America – rural, urban,
Tribal, and everywhere else – has access to cutting-edge cancer diagnostics,
therapeutics, and clinical trials.
·
To target the right treatments to the right
patients — Today, we know cancer as a disease for which we understand too
little about why treatments work for some patients, but not for others. We are
learning more about how to use information about genetics, immune responses,
and other factors to tell which combinations of treatments are likely to work
best in an individual patient.
·
To speed progress against the most deadly and
rare cancers, including childhood cancers — Today, we know cancer as a
disease for which we lack good strategies for developing treatments against
many of the more than 200 distinct types. We can invest in a robust pipeline
for new treatments, and the COVID-19 pandemic response has demonstrated we can
accelerate clinical trials without compromising safety and effectiveness.
·
To support patients, caregivers, and survivors —
Today, we know cancer as a disease in which we do not do enough to help people
and families navigate cancer and its aftermath. We can help people overcome the
medical, financial, and emotional burdens that cancer brings by providing
support to navigate cancer diagnosis, treatment, and survivorship.
·
To learn from all patients — Today, we know
cancer as a disease in which we don’t learn from the experiences of most
patients. We can turn our cancer care system into a learning system. When
asked, most people with cancer are glad to make their data available for
research to help future patients, if it can be done easily while respecting
their privacy. Additionally, the diverse personal experiences of patients and
their families make their input essential in developing approaches to end
cancer as we know it.
Mobilizing the Entire Government
Under the Biden-Harris Administration, the Cancer Moonshot will specifically:
·
Re-establish White House Leadership, with a
White House Cancer Moonshot coordinator in the Executive Office of the
President, to demonstrate the President and First Lady’s personal commitment to
making progress and to leverage the whole-of-government approach and national
response that the challenge of cancer demands.
·
Form a Cancer Cabinet, which will be convened by
the White House, bringing together departments and agencies across government
to address cancer on multiple fronts. These include the Department of Health
and Human Services (HHS), Department of Veterans Affairs (VA), Department of Defense (DOD), Department of Energy (DOE),
Department of Agriculture (USDA), Environmental Protection Agency (EPA), National Institutes of Health (NIH),
National Cancer Institute (NCI),
Food and Drug Administration
(FDA), Centers for
Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC),
Office of Science and Technology Policy (OSTP), Domestic Policy Council (DPC), Gender Policy Council
(GPC), Office of the First Lady (OFL), Office of the Vice President (OVP), Office of Management and Budget (OMB),
Office of Legislative Affairs (OLA), Office of Public Engagement (OPE), along
with additional members, as needed, to help establish and make progress on
Cancer Moonshot goals.
·
Issue a Call to Action on Cancer Screening and
Early Detection:
o To
deliver the message of urgency and increased access to get back on track
after more than 9.5 million missed cancer screenings in the United States as a
result of the COVID-19 pandemic. With regular recommended screenings, we can
often catch cancer when there may be more effective treatment options or even
prevent it from developing by removing pre-cancerous tissue.
o To
help ensure equitable access to screening and prevention through at-home
screening (especially for colon cancer and HPV, the virus that causes
cervical, head, neck and other cancers), mobile screening in
communities without easy access to a clinic, through the community health
networks we have built and strengthened during the COVID-19 pandemic, and
other ways to reduce barriers to cancer screening.
o NCI
will organize the collective efforts of the NCI cancer centers, and other
networks such as the NCI Community Oncology Research Network (NCORP), to offer
new access points to compensate for millions of delayed cancer screenings due
to the pandemic, with a focus on reaching those individuals most at risk.
o Federal
agencies, led by the NCI, will develop a focused program to expeditiously study
and evaluate multicancer detection tests, like we did for COVID-19 diagnostics,
which could help detect cancers when there may be more effective treatment
options.
o The
Department of Health and Human Services (HHS) commits to accelerating
efforts to nearly eliminate cervical cancer through screening and HPV
vaccination, with a particular focus on reaching people who are most at risk.
o The President’s
Cancer panel this week released a report “Closing Gaps in Cancer
Screening” laying out recommendations focused on connecting
people, communities, and systems to increase equity and access.
·
Host a White House Cancer Moonshot Summit,
bringing together agency leadership, patient organizations, biopharmaceutical
companies, the research, public health, and healthcare communities and more to
highlight innovation, progress, and new commitments toward ending cancer as we
know it.
·
Build on a White House Cancer Roundtable
Conversation Series hosted over the last six months, with experts,
including people living with cancer, caregivers, and survivors. These
discussions focused on cancer prevention, early detection, clinical trial
design and access, patient support and navigation, childhood cancer, learning
from all patients and issues relating to equity in access and outcomes. Going
forward, this will include discussions on additional topics and the knowledge gained
will continue to inform this whole-of-government approach on cancer.
·
Require an All-Hands-On-Deck Approach. President
Biden calls on the private sector, foundations, academic institutions,
healthcare providers, and all Americans to take on the mission of reducing
the deadly impact of cancer and improving patient experiences in the diagnosis,
treatment, and survival of cancer. Progress will be informed by people living
with cancer, caregivers, and families and contributed by all parts of the
oncology community and beyond. We invite all Americans to share perspectives
and ideas, and organizations, companies, and institutions to share actions they
plan to take as part of this mission at whitehouse.gov/cancermoonshot.
Connecting
the Dots:
American Cancer
Society was a funder for the Bill, Hillary & Chelsea Clinton Foundation.
Open Society Foundations was a
funder for the Bill, Hillary & Chelsea
Clinton Foundation.
George Soros is
the founder & chairman for the Open
Society Foundations and was the
chairman for the Foundation to Promote Open
Society.
Foundation to Promote Open Society was a funder for the Brookings Institution (think tank).
John Edward Porter was
an honorary trustee at the Brookings
Institution (think tank) and is the chair for Research!America.
John R. Seffrin is
a director at Research!America
and the CEO for the American Cancer Society.
Mark B. McClellan is
a director at Research!America, was
a commissioner for the U.S. Food and Drug
Administration (FDA) and a senior fellow at the Brookings Institution (think tank).
Foundation to Promote Open Society was a funder for the Brookings Institution (think tank).
George Soros was the chairman for the Foundation to Promote Open Society and is an
advisory board member for the Earth
Institute (think tank).
Harold Varmus was
an advisory board member for the Earth
Institute (think tank), a director at the National Institutes of Health (NIH) and is a
director at the National Cancer Institute (NCI).
National Cancer Institute (NCI) is a division of the National Institutes of Health (NIH).
Bernadine P. Healy was
a director at the National Institutes of
Health (NIH) and a trustee
emeritus at the Hudson Institute (think
tank).
Marie-Josee
Kravis is a trustee at the Hudson
Institute (think tank) and an
overseer at the Memorial Sloan-Kettering
Cancer Center.
Foundation to Promote Open Society was a funder for the Hudson Institute (think tank).
George Soros was
the chairman for the Foundation to Promote
Open Society and the founder for
the Soros Fund Management.
Stanley F.
Druckenmiller was a managing director at Soros Fund Management and is an overseer at
the Memorial Sloan-Kettering Cancer Center.
Stephen Friedman is
an overseer at the Memorial Sloan-Kettering
Cancer Center and a trustee at
the Aspen Institute (think tank).
David
H. Koch is an overseer at the Memorial
Sloan-Kettering Cancer Center and
a trustee at the Aspen Institute (think
tank).
Mortimer B.
Zuckerman is an overseer at the Memorial
Sloan-Kettering Cancer Center and
was a trustee at the Aspen Institute (think
tank).
Foundation to Promote Open Society was
a funder for the Aspen Institute (think
tank), the Human Rights Watch and the Millennium
Promise.
George Soros was
the chairman for the Foundation to Promote
Open Society, a benefactor for the Human
Rights Watch and is the founder
& chairman for the Open Society
Foundations.
Open Society Foundations was a funder for the Human Rights Watch and the Atlantic Council of the United States (think tank).
Amy Robbins
Towers is a director at the Human
Rights Watch, a board member for the CDC Foundation and was a director at the Millennium Promise.
CDC Foundation is
a foundation for the Centers for Disease
Control and Prevention (CDC).
Robert Jeffrey was
a board member for the CDC Foundation and is a director at the Atlantic Council of the United States (think tank).
Richard L.
Armitage is a director at the Atlantic
Council of the United States (think tank)
and was the assistant secretary for the U.S. Department
of Defense (DoD).
Harold
Brown is an honorary director for the Atlantic
Council of the United States (think tank)
and was the secretary for the U.S. Department
of Defense (DoD).
Frank C. Carlucci is
an honorary director for the Atlantic
Council of the United States (think tank)
and was the secretary for the U.S. Department
of Defense (DoD).
Henry E. Catto was
the chair emeritus for the Atlantic Council
of the United States (think tank) and
the assistant secretary for the U.S. Department
of Defense (DoD).
Edwin
Dorn is a director at the Atlantic
Council of the United States (think tank) and the undersecretary for
the U.S. Department of Defense (DoD).
Eric S. Edelman is
a director at the Atlantic Council of the
United States (think tank) and was
the undersecretary for the U.S. Department
of Defense (DoD).
Jacques S.
Gansler is a director at the Atlantic
Council of the United States (think tank)
and was the undersecretary for the U.S. Department
of Defense (DoD).
Stephen J. Hadley is
a director at the Atlantic Council of the
United States (think tank) and was
the undersecretary for the U.S. Department
of Defense (DoD).
Paul G. Kaminski was
a director at the Atlantic Council of the
United States (think tank) and the
undersecretary for the U.S. Department
of Defense (DoD).
Zalmay Khalilzad is
a director at the Atlantic Council of the
United States (think tank) and was
the assistant deputy undersecretary for the U.S. Department
of Defense (DoD).
Franklin D.
Kramer is a director at the Atlantic
Council of the United States (think tank)
and was the assistant secretary for the U.S. Department
of Defense (DoD).
Judith A. Miller is
a director at the Atlantic Council of the
United States (think tank) and was
the general counsel for the U.S. Department
of Defense (DoD).
Philip A. Odeen is
a director at the Atlantic Council of the
United States (think tank) and was
the deputy assistant secretary for the U.S. Department
of Defense (DoD).
Sean
O'Keefe is a director at the Atlantic
Council of the United States (think tank)
and was the comptroller & CFO for the U.S. Department of Defense (DoD).
Walter B. Slocombe is
a director at the Atlantic Council of the
United States (think tank) and was the undersecretary for the U.S. Department of Defense (DoD).
James R.
Schlesinger is an honorary director at the Atlantic Council of the United States (think tank) and was the secretary for the U.S. Department of Defense (DoD).
William H. Taft
IV is a director at the Atlantic
Council of the United States (think tank)
and was the general counsel for the U.S. Department
of Defense (DoD).
Togo D. West Jr. is
a director at the Atlantic Council of the
United States (think tank) and was
the general counsel for the U.S. Department
of Defense (DoD).
Dov S. Zakheim is
a director at the Atlantic Council of the
United States (think tank) and was
the undersecretary for the U.S. Department
of Defense (DoD).
William J. Perry is
an honorary director for the Atlantic
Council of the United States (think tank) and was the secretary for
the U.S. Department of Defense (DoD).
Robert S. McNamara was
an honorary director for the Atlantic
Council of the United States (think tank), the secretary for
the U.S. Department of Defense (DoD) and an honorary trustee at the Brookings Institution (think tank).
Open Society Foundations was a funder for the Atlantic Council of the United States (think tank)
and the Bill, Hillary & Chelsea Clinton
Foundation.
George Soros is the
founder & chairman for the Open Society
Foundations and was the
chairman for the Foundation to Promote Open
Society.
Foundation to Promote Open Society was a funder for the Brookings Institution (think tank).
John Edward Porter was
an honorary trustee at the Brookings
Institution (think tank) and is the chair for Research!America.
Mark B. McClellan is
a director at Research!America, was
a commissioner for the U.S. Food and Drug
Administration (FDA) and a senior
fellow at the Brookings Institution (think
tank).
John R. Seffrin is
a director at Research!America and the CEO for the American Cancer Society.
American
Cancer Society was a funder for the Bill,
Hillary & Chelsea Clinton Foundation.
Open Society Foundations was a
funder for the Bill, Hillary & Chelsea
Clinton Foundation.
George Soros is
the founder & chairman for the Open
Society Foundations and an
advisory board member for the Earth
Institute (think tank).
Harold Varmus was
an advisory board member for the Earth
Institute (think tank), a director at the National Institutes of Health (NIH) and is a
director at the National Cancer Institute (NCI).
National Cancer Institute (NCI) is a division of the National Institutes of Health (NIH).
Ezekiel Emanuel was
the founding chair of the Department of Bioethics at the National Institutes of Health (NIH), a faculty
member at the Dana-Farber Cancer Institute,
the health care policy adviser at the U.S.
Office of Management and Budget for
the Barack Obama administration
and is a senior fellow at the Center for
American Progress.
Jeanne Lambrew was
the health policy associate director and the U.S.
Office of Management and Budget and a senior fellow at the Center for American Progress.
George Soros was
a supporter for the Center for American
Progress and is the chairman for the Foundation to Promote Open Society.
Foundation to Promote Open Society was a funder for the Center for American Progress.
Bill & Melinda Gates Foundation was a funder for the Center for American Progress.
Christopher
Edley Jr. is a U.S. program advisory panel member for the Bill & Melinda Gates Foundation and was an associate director for economics &
government for the U.S. Office of
Management and Budget.
James A. Nussle is
a U.S. program advisory panel member for the Bill
& Melinda Gates Foundation and
was a director at the U.S. Office of
Management and Budget.
Sylvia
Mathews Burwell was the president, global development for the Bill & Melinda Gates Foundation, the
deputy director for the U.S. Office of
Management and Budget and is a
director at the U.S. Office of Management
and Budget.
Bill & Melinda Gates Foundation was
a funder for the Committee for Economic
Development.
Foundation to Promote Open Society was a funder for the Committee for Economic Development.
George Soros was
the chairman for the Foundation to Promote
Open Society.
John P. White is
a trustee at the Committee for Economic
Development and was the deputy
director for the U.S. Office of Management
and Budget.
George P. Shultz is
a trustee at the Committee for Economic
Development and was a director at
the U.S. Office of Management and Budget.
Donna S.
Morea was a trustee at the Committee
for Economic Development and the EVP for the CGI Group Inc.
CGI Group Inc. was the contractor that developed Healthcare.gov web
site for Obamacare.
Obamacare is Barack Obama’s signature
policy initiative.
Melody C. Barnes is Barack Obama’s golf
partner, was the domestic policy council, director for the Barack Obama administration, the domestic policy council, director for
the Barack Obama administration and the EVP for the Center for American Progress.
George Soros was
a supporter for the Center for American
Progress and is the chairman for
the Foundation to Promote Open Society.
Foundation to Promote Open Society was a funder for the Center for American Progress.
Bill & Melinda Gates Foundation was
a funder for the Center for American
Progress.
Joseph Romm is
a senior fellow at the Center for American
Progress and was the acting assistant secretary for the U.S. Department of Energy (DOE).
Steven J. Spinner was
a senior fellow at the Center for American
Progress, encouraged prompt decision on DOE loan for Solyndra, Inc., and a loan programs adviser
for the U.S. Department of Energy
(DOE).
Donald M. Berwick is
a senior fellow at the Center for American
Progress and was the
administrator for the Centers for Medicare
& Medicaid Services (CMS).
Ezekiel Emanuel is
a senior fellow at the Center for American
Progress, was a faculty member at the Dana-Farber Cancer Institute, the health care
policy adviser at the U.S. Office of
Management and Budget for
the Barack Obama administration and
the founding chair of the Department of Bioethics at the National Institutes of Health (NIH).
National Cancer Institute (NCI) is a division of the National Institutes of Health (NIH).
Harold Varmus is
a director at the National Cancer Institute
(NCI) was a director at the National Institutes of Health (NIH) and an advisory board member for the Earth Institute (think tank).
George Soros is an advisory board member for the Earth Institute (think tank) the founder & chairman for the Open Society Foundations and the founder of Soros Fund Management.
Open Society Foundations was a funder for the Atlantic Council of the United States (think tank).
James R.
Schlesinger was an honorary director for the Atlantic Council of the United States (think tank)
and the secretary for the U.S. Department
of Energy (DOE).
Catherine
Radford Zoi was the assistant secretary for energy efficiency at the U.S. Department of Energy (DOE) for the Barack
Obama administration and is an executive for Silver Lake Kraftwerk Fund.
Soros Fund Management was a partner at Silver Lake Kraftwerk Fund.
Resources:
Past Research
American Cancer Society
(Past Research on the American Cancer Society)
MONDAY, SEPTEMBER 12, 2016
https://thesteadydrip.blogspot.com/2016/09/american-cancer-society.html
FDA Fails to Protect
Americans from Dangerous Drugs and Unsafe Foods (Past
Research on the FDA)
SUNDAY, MAY 10, 2015
https://thesteadydrip.blogspot.com/2015/05/fda-fails-to-protect-americans-from.html
*UPDATED* The List:
Unnecessarily Shut Down by Obama to Inflict Public Pain (Past Research on the National Cancer Institute (NCI)
& the National Institutes of Health (NIH))
MONDAY, OCTOBER 7, 2013
https://thesteadydrip.blogspot.com/2013/10/updated-list-unnecessarily-shut-down-by.html
The CDC: A Truly
Corrupt and Dangerous Organization (Past Research
on the CDC)
TUESDAY, JANUARY 5, 2016
https://thesteadydrip.blogspot.com/2016/01/the-cdc-truly-corrupt-and-dangerous.html
U.S. Marine Dies in
Afghanistan on New Year's Day (Past Research on the
U.S. Department of Defense (DoD))
SUNDAY, JANUARY 5, 2014
https://thesteadydrip.blogspot.com/2014/01/us-marine-dies-in-afghanistan-on-new.html
Obama appoints Jeffrey
Zients to fix healthcare website (Past Research on
the U.S. Office of Management and Budget (OMB))
SATURDAY, OCTOBER 26, 2013
https://thesteadydrip.blogspot.com/2013/10/obama-appoints-jeffrey-zients-to-fix.html
Solyndra Sequel: 'We're
Back in Business' with $4 Billion Energy Loans (Past
Research on the (U.S. Department of Energy (DOE))
FRIDAY, APRIL 18, 2014
No comments:
Post a Comment